9-132897553-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_ModerateBP6BS2_Supporting

The NM_000368.5(TSC1):​c.2683G>A​(p.Val895Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000386 in 1,555,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000070 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000035 ( 0 hom. )

Consequence

TSC1
NM_000368.5 missense

Scores

1
1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.81
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08602604).
BP6
Variant 9-132897553-C-T is Benign according to our data. Variant chr9-132897553-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 411268.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS2
High AC in GnomAdExome4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC1NM_000368.5 linkc.2683G>A p.Val895Ile missense_variant Exon 21 of 23 ENST00000298552.9 NP_000359.1 Q92574-1Q86WV8X5D9D2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkc.2683G>A p.Val895Ile missense_variant Exon 21 of 23 1 NM_000368.5 ENSP00000298552.3 Q92574-1
TSC1ENST00000490179.4 linkc.2683G>A p.Val895Ile missense_variant Exon 22 of 24 3 ENSP00000495533.2 A0A2R8Y6S8

Frequencies

GnomAD3 genomes
AF:
0.00000703
AC:
1
AN:
142322
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000236
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000404
AC:
1
AN:
247830
Hom.:
0
AF XY:
0.00000746
AC XY:
1
AN XY:
133976
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000337
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000354
AC:
5
AN:
1413308
Hom.:
0
Cov.:
37
AF XY:
0.00000285
AC XY:
2
AN XY:
702798
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000590
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000702
AC:
1
AN:
142404
Hom.:
0
Cov.:
31
AF XY:
0.0000146
AC XY:
1
AN XY:
68348
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000236
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.00000824
AC:
1
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tuberous sclerosis 1 Uncertain:1Benign:1
Aug 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 31, 2023
Clinical Genomics Laboratory, Washington University in St. Louis
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The TSC1 c.2683G>A (p.Val895Ile) variant was identified at near heterozygous allelic fraction of 48%, a frequency which may be consistent with it being of germline origin. To our knowledge, this variant has not been reported in the medical literature and is only observed on 1/142,322 alleles in the general population (gnomAD v3.1.2), indicating that it is not a common variant. The variant has been reported in the ClinVar database as a variant of uncertain significance by one submitter and a likely benign variant by another submitter (ClinVar Variation ID: 411268). Computational predictors suggest that the variant does not impact TSC1 function. Due to limited information, and based on the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of the TSC1 c.2683G>A (p.Val895Ile) variant is uncertain at this time. -

Hereditary cancer-predisposing syndrome Uncertain:1
Jun 06, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.V895I variant (also known as c.2683G>A), located in coding exon 19 of the TSC1 gene, results from a G to A substitution at nucleotide position 2683. The valine at codon 895 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.30
T;.;T;.;.;T;.;T;.;.;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.13
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.82
.;T;T;T;T;.;.;.;T;T;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.086
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
1.2
L;.;L;.;.;L;.;L;.;.;.
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.38
N;N;N;.;.;.;.;.;.;.;.
REVEL
Benign
0.15
Sift
Benign
0.070
T;T;T;.;.;.;.;.;.;.;.
Sift4G
Benign
0.39
T;T;T;.;.;.;.;.;.;.;.
Polyphen
0.13
B;.;B;.;.;B;.;B;.;.;.
Vest4
0.34
MutPred
0.22
Gain of methylation at K890 (P = 0.1433);.;Gain of methylation at K890 (P = 0.1433);.;.;Gain of methylation at K890 (P = 0.1433);.;Gain of methylation at K890 (P = 0.1433);.;.;.;
MVP
0.37
MPC
0.42
ClinPred
0.13
T
GERP RS
2.3
Varity_R
0.091
gMVP
0.038

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs576476807; hg19: chr9-135772940; API